In this interview, we explore global and local efforts to combat viral hepatitis with Lindsey Hiebert, Deputy Director of the Coalition for Global Hepatitis Elimination
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in
Rise and shine, everyone, another busy day is on the way. We can tell because the pace of motor vehicles passing by our window is
One Medicine is a concept whereby human and animal medicine advance hand in hand, with vets, doctors, nurses, and researchers all collaborating to ensure that
Early life exposure to potent AHR agonists on gut microbiota and its potential effects on metabolic health later in life.
Glucagon-like peptide-1 receptor (GLP-1R) products [a class of incretin mimetic medicines for the treatment of type 2 diabetes and obesity] generated more than $37 billion
You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in
Researchers evaluated the individual and combined effects of workplace psychosocial stressors, such as effort-reward imbalance and job strain, on atrial fibrillation incidence.
In the 18 months after Francine Milano was diagnosed with a recurrence of the ovarian cancer she thought she’d beaten 20 years ago, she traveled
Eli Lilly’s obesity drug Zepbound significantly cut the risk of developing type 2 diabetes, showing the benefits of long-term use of the blockbuster therapy. In